Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish

Neurotoxicology and Teratology

Volumn 40, Issue , 2013, Pages 46-58

  Aluru, Neelakanteswar ^a   Deak, Kristina L ^a,c   Jenny, Matthew J ^a,b   Hahn, Mark E ^a  

^a WOODS HOLE OCEANOGRAPHIC INSTITUTION   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c MOTE MARINE LABORATORY   (United States)

Author keywords

Development; Microarrays; MicroRNA; Teratogens; Zebrafish

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 10C; MICRORNA 122; MICRORNA 124; MICRORNA 132; MICRORNA 135A; MICRORNA 140; MICRORNA 16A; MICRORNA 16B; MICRORNA 182; MICRORNA 18C; MICRORNA 192; MICRORNA 194A; MICRORNA 21; MICRORNA 212; MICRORNA 217; MICRORNA 22A; MICRORNA 22B; MICRORNA 27C; MICRORNA 29A; MICRORNA 29B; MICRORNA 34; MICRORNA 451; MICRORNA 455; MICRORNA 457B; MICRORNA 724; MICRORNA 96; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ABNORMAL BEHAVIOR; ALTERED SWIMMING BEHAVIOR; AMOT GENE; ANIMAL EXPERIMENT; ARTICLE; BDNF GENE; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; DOWN REGULATION; DUST EXPOSURE; EMBRYO; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; MALE; MICROARRAY ANALYSIS; MMP9 GENE; MUSCLE TWITCH; NCOR2 GENE; NERVE CELL DIFFERENTIATION; NONHUMAN; PAIP2 GENE; PERICARDIAL EFFUSION; PHENOTYPE; PIGMENTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINE DISEASE; STARTLE REFLEX; SWIMMING; TERATOGENICITY; U6 GENE; UPREGULATION; ZEBRA FISH;

DEVELOPMENT; MICROARRAYS; MICRORNA; TERATOGENS; ZEBRAFISH;

ANIMALS; CENTRAL NERVOUS SYSTEM; EMBRYONIC DEVELOPMENT; MICRORNAS; VALPROIC ACID; ZEBRAFISH;

EID: 84886813828     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2013.10.001     Document Type: Article

References (95)

1. Aase K., Ernkvist M., Ebarasi L., Jakobsson L., Majumdar A., Yi C., et al. Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev 2007, 21:2055-2068.
2. Agostini M., Tucci P., Killick R., Candi E., Sayan B.S., Rivetti di Val Cervo P., et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A 2011, 108:21093-21098.
3. Agostini M., Tucci P., Steinert J.R., Shalom-Feuerstein R., Rouleau M., Aberdam D., et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A 2011, 108:21099-21104.
4. Alliey-Rodriguez N., Zhang D., Badner J.A., Lahey B.B., Zhang X., Dinwiddie S., et al. Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet 2011, 21:190-194.
5. Alvarez-Saavedra M., Antoun G., Yanagiya A., Oliva-Hernandez R., Cornejo-Palma D., Perez-Iratxeta C., et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 2011, 20:731-751.
6. Aqeilan R.I., Calin G.A., Croce C.M. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010, 17:215-220.
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a pratical and powerful approach to multiple testing. J. R. Stat. Soc. Ser B. 1995, 57:289-300.
9. Blaheta R.A., Nau H., Michaelis M., Cinatl J. Valproate and valproate-analogues: potent tools to fight against cancer. Curr Med Chem 2002, 9:1417-1433.
10. Brannen K.C., Panzica-Kelly J.M., Danberry T.L., Augustine-Rauch K.A. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol 2010, 89:66-77.
11. Bratt A., Birot O., Sinha I., Veitonmaki N., Aase K., Ernkvist M., et al. Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 2005, 280:34859-34869.
12. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
13. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009, 12:399-408.
14. Coolen M., Bally-Cuif L. MicroRNAs in brain development and physiology. Curr Opin Neurobiol 2009, 19:461-470.
15. Cowden J., Padnos B., Hunter D., MacPhail R., Jensen K., Padilla S. Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos. Reprod Toxicol 2012, 33:165-173.
16. de Esch C., Slieker R., Wolterbeek A., Woutersen R., de Groot D. Zebrafish as potential model for developmental neurotoxicity testing: a mini review. Neurotoxicol Teratol 2012, 34:545-553.
17. Delay C., Mandemakers W., Hebert S.S. MicroRNAs in Alzheimer's disease. Neurobiol Dis 2012, 46:285-290.
18. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
19. Farooq M., Sulochana K.N., Pan X., To J., Sheng D., Gong Z., et al. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev Biol 2008, 317:336-353.
20. Fayyad-Kazan H., Rouas R., Merimi M., El Zein N., Lewalle P., Jebbawi F., et al. Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem 2010, 285:20481-20491.
21. Fiore R., Siegel G., Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta 2008, 1779:471-478.
22. Foley N.H., Bray I., Watters K.M., Das S., Bryan K., Bernas T., et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ 2011, 18:1089-1098.
23. Fornari F., Gramantieri L., Giovannini C., Veronese A., Ferracin M., Sabbioni S., et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009, 69:5761-5767.
24. Gao F.B. Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci 2008, 31:20-26.
25. Giraldez A.J., Cinalli R.M., Glasner M.E., Enright A.J., Thomson J.M., Baskerville S., et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005, 308:833-838.
26. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001, 20:6969-6978.
27. Gould T.D., Manji H.K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 2002, 8:497-511.
28. Gueta K., Molotski N., Gerchikov N., Mor E., Savion S., Fein A., et al. Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype. BMC Dev Biol 2010, 10:20.
29. Gurvich N., Tsygankova O.M., Meinkoth J.L., Klein P.S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004, 64:1079-1086.
30. Gurvich N., Berman M.G., Wittner B.S., Gentleman R.C., Klein P.S., Green J.B. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J 2005, 19:1166-1168.
31. Hahn C.G., Umapathy, Wang H.Y., Koneru R., Levinson D.F., Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 2005, 39:355-363.
32. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 2008, 105:6415-6420.
33. Herrmann K. Effects of the anticonvulsant drug valproic acid and related substances on the early development of the zebrafish (Brachydanio rerio). Toxicol In Vitro 1993, 7:41-54.
34. Hunsberger J.G., Fessler E.B., Chibane F.L., Leng Y., Maric D., Elkahloun A.G., et al. Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res 2013, 5:450-464.
35. Jenny M.J., Aluru N., Hahn M.E. Effects of short-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on microRNA expression in zebrafish embryos. Toxicol Appl Pharmacol 2012, 264:262-273.
36. Jovicic A., Zaldivar Jolissaint J.F., Moser R., Silva Santos Mde F., Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS One 2013, 8:e54222.
37. Kole A.J., Swahari V., Hammond S.M., Deshmukh M. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev 2011, 25:125-130.
38. Krichevsky A.M., Sonntag K.C., Isacson O., Kosik K.S. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006, 24:857-864.
39. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
40. Laeng P., Pitts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H., et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004, 91:238-251.
41. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739.
42. Lee S., Jung J.W., Park S.B., Roh K., Lee S.Y., Kim J.H., et al. Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Cell Mol Life Sci 2011, 68:325-336.
43. Lee S.T., Chu K., Im W.S., Yoon H.J., Im J.Y., Park J.E., et al. Altered microRNA regulation in Huntington's disease models. Exp Neurol 2011, 227:172-179.
44. Levin E.D., Chrysanthis E., Yacisin K., Linney E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol Teratol 2003, 25:51-57.
45. Levin E.D., Sledge D., Roach S., Petro A., Donerly S., Linney E. Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol 2011, 33:668-673.
46. Li X., Jia S., Wang S., Wang Y., Meng A. Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. Blood 2009, 114:5464-5472.
47. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
48. Lin C.J., Gong H.Y., Tseng H.C., Wang W.L., Wu J.L. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2008, 375:315-320.
49. Linney E., Upchurch L., Donerly S. Zebrafish as a neurotoxicological model. Neurotoxicol Teratol 2004, 26:709-718.
50. Linney E., Perz-Edwards A., Kelley B. Identification and characterization of a functional zebrafish smrt corepressor (ncor2). Gene 2011, 486:31-36.
51. -δδCT. method. Methods 2001, 25:402-408.
52. Lopez-Romero P. Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library. BMC Genomics. 2011, 12:64.
53. Lorenzen J., Kumarswamy R., Dangwal S., Thum T. MicroRNAs in diabetes and diabetes-associated complications. RNA Biol 2012, 9:820-827.
54. Lund A.H. miR-10 in development and cancer. Cell Death Differ 2010, 17:209-214.
55. Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001, 13:477-483.
56. Marks P.A., Rifkind R.A., Richon V.M., Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001, 7:759-760.
57. Mellios N., Sur M. The emerging role of microRNAs in schizophrenia and autism spectrum disorders. Front Psychiatry 2012, 3:39.
58. Miller B.H., Zeier Z., Xi L., Lanz T.A., Deng S., Strathmann J., et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A 2012, 109:3125-3130.
59. Minones-Moyano E., Porta S., Escaramis G., Rabionet R., Iraola S., Kagerbauer B., et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 2011, 20:3067-3078.
60. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod Toxicol 2009, 28:1-10.
61. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001, 276:36734-36741.
62. Remenyi J., Hunter C.J., Cole C., Ando H., Impey S., Monk C.E., et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010, 428:281-291.
63. Saito Y., Hibino S., Saito H. Alterations of epigenetics and microRNAs in hepatocellular carcinoma. Hepatol Res 2013, 10.1111/hepr.12147.
64. Salta E., De Strooper B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol 2012, 11:189-200.
65. Scalzo F.M., Levin E.D. The use of zebrafish (Danio rerio) as a model system in neurobehavioral toxicology. Neurotoxicol Teratol 2004, 26:707-708.
66. Schonrock N., Ke Y.D., Humphreys D., Staufenbiel M., Ittner L.M., Preiss T., et al. Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 2010, 5:e11070.
67. Selderslaghs I.W., Van Rompay A.R., De Coen W., Witters H.E. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 2009, 28:308-320.
68. Selderslaghs I.W., Hooyberghs J., Blust R., Witters H.E. Assessment of the developmental neurotoxicity of compounds by measuring locomotor activity in zebrafish embryos and larvae. Neurotoxicol Teratol 2013, 37:44-56.
69. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004, 5:R13.
70. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
71. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 22:897-899.
72. Soares A.R., Pereira P.M., Ferreira V., Reverendo M., Simoes J., Bezerra A.R., et al. Ethanol exposure induces upregulation of specific microRNAs in zebrafish embryos. Toxicol Sci 2012, 127:18-28.
73. Sylvain N.J., Brewster D.L., Ali D.W. Embryonic ethanol exposure alters synaptic properties at zebrafish neuromuscular junctions. Neurotoxicol Teratol 2011, 33:313-321.
74. Tal T.L., Tanguay R.L. Non-coding RNAs-novel targets in neurotoxicity. Neurotoxicology 2012, 33:530-544.
75. Tal T.L., Franzosa J.A., Tilton S.C., Philbrick K.A., Iwaniec U.T., Turner R.T., et al. MicroRNAs control neurobehavioral development and function in zebrafish. FASEB J 2012, 26:1452-1461.
76. Teixido E., Pique E., Gomez-Catalan J., Llobet J.M. Assessment of developmental delay in the zebrafish embryo teratogenicity assay. Toxicol In Vitro 2013, 27:469-478.
77. Terbach N., Williams R.S. Structure-function studies for the panacea, valproic acid. Biochem Soc Trans 2009, 37:1126-1132.
78. Terbach N., Shah R., Kelemen R., Klein P.S., Gordienko D., Brown N.A., et al. Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium. J Cell Sci 2011, 124:2267-2276.
79. Thatcher E.J., Flynt A.S., Li N., Patton J.R., Patton J.G. MiRNA expression analysis during normal zebrafish development and following inhibition of the Hedgehog and Notch signaling pathways. Dev Dyn 2007, 236:2172-2180.
80. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009, 49:1571-1582.
81. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 2005, 102:16426-16431.
82. Walmod P.S., Foley A., Berezin A., Ellerbeck U., Nau H., Bock E., et al. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues. Cell Motil Cytoskeleton 1998, 40:220-237.
83. Walmod P.S., Skladchikova G., Kawa A., Berezin V., Bock E. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton. Cell Motil Cytoskeleton 1999, 42:241-255.
84. Wanet A., Tacheny A., Arnould T., Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 2012, 40:4742-4753.
85. Wang W.X., Huang Q., Hu Y., Stromberg A.J., Nelson P.T. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 2011, 121:193-205.
86. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio) 2000, Univ. of Oregon Press, Eugene. 4th ed.
87. Wienholds E., Plasterk R.H. MicroRNA function in animal development. FEBS Lett 2005, 579:5911-5922.
88. Wienholds E., Kloosterman W.P., Miska E., Alvarez-Saavedra E., Berezikov E., de Bruijn E., et al. MicroRNA expression in zebrafish embryonic development. Science 2005, 309:310-311.
89. Wiltse J. Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin-developmental effects of valproic acid. Crit Rev Toxicol 2005, 35:727-738.
90. Woltering J.M., Durston A.J. MiR-10 represses HoxB1a and HoxB3a in zebrafish. PLoS One 2008, 3:e1396.
91. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 2001, 276:31674-31683.
92. Zeng Y. Regulation of the mammalian nervous system by microRNAs. Mol Pharmacol 2009, 75:259-264.
93. Zhang L., Li Y.Y., Zeng H.C., Wei J., Wan Y.J., Chen J., et al. MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate. J Appl Toxicol 2011, 31:210-222.
94. Zhao Y., Xiong Q., Xie P. Analysis of microRNA expression in embryonic developmental toxicity induced by MC-RR. PLoS One 2011, 6:e22676.
95. Zhou R., Yuan P., Wang Y., Hunsberger J.G., Elkahloun A., Wei Y., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.